The cannabis information platform Leafly announced a strategic partnership Tuesday with the American Medical Marijuana Physicians Association, the world’s largest physician-based cannabis association.
The partnership is focused on helping physicians provide cannabis-based care to patients.
The collaboration follows an increase in demand for cannabinoid-based medicines, with 33 states legalizing medical cannabis and more than 90% of Americans being in favor of federal legalization.
More Medical Cannabis Creates A Greater Need For Information
As part of the partnership, Leafly will offer physicians a subscription that includes a presence on its site, as well as an AMMPA membership.
The two organization will also collaborate on events that promote medical cannabis education, as well as an online learning course that deals with medical cannabis topics.
A vast majority of Americans are in favor of legal medical cannabis, Leafly CEO Tim Leslie told Benzinga.
"As this support has grown, so too has the need for information and education," he said.
"Leafly is proud to be a trusted resource for finding safe and legal adult-use recreational and medicinal cannabis."
The partnership with the AMMPA is "the next step" in building education and trust, the CEO said.
With 2 million Americans now having legal access to medical cannabis, the AMMPA is excited to partner with Leafly to ensure that health care providers have trusted, reliable information, said Dr. Mark Chaet, the organization's president.
"We want to help equip doctors with the best patient care tools available to them, and in particular the untapped potential of medicinal cannabinoids. Through this partnership, we’re looking forward to educating and empowering the entire medical community, and establishing cannabinoids as a trusted and accessible form of care."
Related Links:
Exclusive: Leafly Launches Cannabis Lab Testing Certification Program
Beyond Indica And Sativa: Leafly Launches Graphic Platform For Identifying Cannabis Strains
Photo courtesy of Leafly.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.